331 related articles for article (PubMed ID: 15985222)
1. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection.
Narita K; Hu DL; Tsuji T; Nakane A
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):389-96. PubMed ID: 18312579
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
Narita K; Hu DL; Asano K; Nakane A
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of glutathione S-transferase-fused mutant staphylococcal enterotoxin C against Staphylococcus aureus-induced bovine mastitis.
Cui JC; Zhang BJ; Lin YC; Wang QK; Qian AD; Nakane A; Hu DL; Tong GZ
Vet Immunol Immunopathol; 2010 May; 135(1-2):64-70. PubMed ID: 19959244
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.
Narita K; Hu DL; Asano K; Nakane A
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens.
Bavari S; Ulrich RG; LeClaire RD
J Infect Dis; 1999 Oct; 180(4):1365-9. PubMed ID: 10479174
[TBL] [Abstract][Full Text] [Related]
10. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
Uppalapati SR; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
[TBL] [Abstract][Full Text] [Related]
11. Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1.
Rubinchik E; Chow AW
Vaccine; 2000 Apr; 18(21):2312-20. PubMed ID: 10717352
[TBL] [Abstract][Full Text] [Related]
12. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
Wahlsten JL; Mills CD; Ramakrishnan S
J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
[TBL] [Abstract][Full Text] [Related]
13. A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.
Hu DL; Cui JC; Omoe K; Sashinami H; Yokomizo Y; Shinagawa K; Nakane A
Infect Immun; 2005 Jan; 73(1):174-80. PubMed ID: 15618152
[TBL] [Abstract][Full Text] [Related]
14. Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection.
Hu DL; Omoe K; Narita K; Cui JC; Shinagawa K; Nakane A
Microbes Infect; 2006; 8(14-15):2841-8. PubMed ID: 17090392
[TBL] [Abstract][Full Text] [Related]
15. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.
Verkaik NJ; de Vogel CP; Boelens HA; Grumann D; Hoogenboezem T; Vink C; Hooijkaas H; Foster TJ; Verbrugh HA; van Belkum A; van Wamel WJ
J Infect Dis; 2009 Mar; 199(5):625-32. PubMed ID: 19199541
[TBL] [Abstract][Full Text] [Related]
16. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
Nilsson IM; Verdrengh M; Ulrich RG; Bavari S; Tarkowski A
J Infect Dis; 1999 Oct; 180(4):1370-3. PubMed ID: 10479175
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
Kum WW; Chow AW
J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
[TBL] [Abstract][Full Text] [Related]
18. Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor.
Fast DJ; Schlievert PM; Nelson RD
J Immunol; 1988 Feb; 140(3):949-53. PubMed ID: 3339245
[TBL] [Abstract][Full Text] [Related]
19. The role of gamma interferon in acquired host resistance against Staphylococcus aureus infection in mice.
Sasaki S; Tagawa Y; Iwakura Y; Nakane A
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):367-74. PubMed ID: 16553809
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
